In 2013, Roger Williams’s group in the LMB’s PNAC Division published findings from a study conducted with researchers at the University of Cambridge, the Babraham Institute and clinicians from Addenbrooke’s Hospital. Together, the team identified a rare genetic mutation which causes a condition now known as Activated PI3K-d Syndrome (APDS), which weakens the immune system […]
First patient treated for APDS, a rare inherited disorder identified by collaborative Cambridge team including Roger Williams’s group
HR Advisors Ash Munday, Christina Karikides and Callum Armstrong reflect on earning their CIPD Diplomas
The HR Advisors share their motivations and experience of coordinating pursuing the CIPD qualification studies with their job.
Kelly Nguyen awarded 2025 Lister Prize
Kelly Nguyen, Group Leader in the LMB’s Structural Studies Division, has been announced as one of the 2025 recipients of the prestigious Lister Institute Research Prize.
Sortera Bio has raised £7.5m pre-seed investment from AstraZeneca, BioNTech and CIC
Business Weekly reports that Sortera Bio, an LMB spinout company, has attracted backers for a £7.5m pre-seed round to power AI models for drug discovery. The round was led by Cambridge Innovation Capital (CIC) with participation from AstraZeneca and BioNTech. More…
The LMB licences ‘tRNA Display’ technology to Constructive.Bio
Business Weekly reports that Constructive.Bio, an LMB spinout company based on Jason Chin’s research, now holds the exclusive licence to ‘tRNA Display’ technology. The company can start a full commercial rollout of its platform – enabling next-gen synthetic protein engineering applications for pharma, agriculture and advanced materials. More…
Tanmay Bharat awarded EMBO Gold Medal
Tanmay Bharat, Group Leader in the LMB’s Structural Studies Division, received EMBO’s Gold Medal in recognition of his work on prokaryotic surface molecules.